Log in

NYSE:MYOVMyovant Sciences SEC Filings & 10K Form

$8.08
+0.38 (+4.94 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.64
Now: $8.08
$8.18
50-Day Range
$6.55
MA: $9.37
$12.35
52-Week Range
$4.14
Now: $8.08
$25.14
Volume585,479 shs
Average Volume1.03 million shs
Market Capitalization$725.50 million
P/E RatioN/A
Dividend YieldN/A
Beta2.2

SEC Filings

Myovant Sciences (NYSE:MYOV) SEC Filings

DateFilerForm TypeView
04/03/2020
2:04 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
9:55 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2020
10:34 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
12:11 PM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D/A
03/26/2020
10:39 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
2:15 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
1:10 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:21 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:13 PM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D/A
02/24/2020
5:38 PM
Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
2:20 PM
JANUS HENDERSON GROUP PLC (Filed by)
Myovant Sciences (Subject)
Form SC 13G
02/10/2020
7:44 AM
Myovant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/10/2020
7:40 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
5:16 AM
Myovant Sciences (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13G/A
01/24/2020
5:14 AM
Myovant Sciences (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13G/A
01/16/2020
4:28 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:42 AM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D
01/03/2020
5:02 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2020
7:05 AM
Myovant Sciences (Filer)
Form DEF 14C
12/31/2019
3:45 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2019
3:45 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
12/30/2019
6:14 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
6:13 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
4:15 PM
Myovant Sciences (Issuer)
Nomura Hiroshi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/30/2019
4:13 PM
Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/30/2019
8:16 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
3:06 PM
Myovant Sciences (Filer)
Form PRE 14C
12/19/2019
3:25 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
3:28 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
5:08 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:45 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
11/27/2019
3:45 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
8:28 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:56 AM
Myovant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:40 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
5:05 AM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
10/31/2019
8:24 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
4:06 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
08/27/2019
3:59 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:58 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:55 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:53 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:50 PM
Myovant Sciences (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:48 PM
Myovant Sciences (Issuer)
Sebelius Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:46 PM
Myovant Sciences (Issuer)
POTTER MYRTLE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:44 PM
GUINAN MARK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:42 PM
Curran Terrie (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:06 PM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
4:03 PM
Myovant Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/06/2019
3:33 PM
Myovant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2019
3:05 PM
Myovant Sciences (Filer)
Form DEF 14A
07/16/2019
4:29 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
07/15/2019
8:37 PM
Lo Andrew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
8:32 PM
Machado Patrick (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
7:34 PM
HALVORSEN OLE ANDREAS (Reporting)
Myovant Sciences (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VGE III Portfolio Ltd. (Reporting)
Viking Global Equities II LP (Reporting)
Viking Global Equities LP (Reporting)
Viking Global Equities Master Ltd. (Reporting)
VIKING GLOBAL PERFORMANCE LLC (Reporting)
Viking Long Fund GP LLC (Reporting)
Viking Long Fund Master Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
7:33 PM
HALVORSEN OLE ANDREAS (Reporting)
Myovant Sciences (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
6:50 PM
Myovant Sciences (Issuer)
SoftBank Vision Fund L.P. (Reporting)
SVF Investments Ltd (0001716729) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:59 PM
Myovant Sciences (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
07/12/2019
3:52 PM
Dexcel Pharma Technologies Ltd. (Reporting)
Dexxon Holdings Ltd. (Reporting)
Myovant Sciences (Issuer)
Oren Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:48 PM
Dexxon Holdings Ltd. (Filed by)
Myovant Sciences (Subject)
Form SC 13D/A
07/12/2019
3:41 PM
Myovant Sciences (Subject)
QVT Financial LP (Filed by)
Form SC 13D/A
07/12/2019
3:31 PM
Myovant Sciences (Subject)
SVF Investments Ltd (0001716729) (Filed by)
Form SC 13D/A
07/12/2019
3:28 PM
Myovant Sciences (Issuer)
QVT Associates GP LLC (Reporting)
QVT Fund V LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:26 PM
Myovant Sciences (Subject)
QVT Financial LP (Filed by)
Form SC 13D
06/14/2019
4:16 PM
Lo Andrew (Filed by)
Myovant Sciences (Subject)
Form SC 13D
06/14/2019
4:15 PM
Machado Patrick (Filed by)
Myovant Sciences (Subject)
Form SC 13D
06/14/2019
4:12 PM
Dexxon Holdings Ltd. (Filed by)
Myovant Sciences (Subject)
Form SC 13D
06/14/2019
4:12 PM
Myovant Sciences (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D
06/14/2019
4:01 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D
06/13/2019
2:47 PM
HALVORSEN OLE ANDREAS (Reporting)
Myovant Sciences (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
2:45 PM
HALVORSEN OLE ANDREAS (Reporting)
Myovant Sciences (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VGE III Portfolio Ltd. (Reporting)
Viking Global Equities II LP (Reporting)
Viking Global Equities LP (Reporting)
Viking Global Equities Master Ltd. (Reporting)
VIKING GLOBAL PERFORMANCE LLC (Reporting)
Viking Long Fund GP LLC (Reporting)
Viking Long Fund Master Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:55 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
7:05 PM
Myovant Sciences (Issuer)
QVT Associates GP LLC (Reporting)
QVT Fund V LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:30 PM
Myovant Sciences (Issuer)
SoftBank Vision Fund L.P. (Reporting)
SVF Investments Ltd (0001716729) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:30 PM
Machado Patrick (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:29 PM
Dexcel Pharma Technologies Ltd. (Reporting)
Dexxon Holdings Ltd. (Reporting)
Myovant Sciences (Issuer)
Oren Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:07 PM
Lo Andrew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:00 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:22 PM
Myovant Sciences (Subject)
SVF Investments Ltd (0001716729) (Filed by)
Form SC 13D/A
06/04/2019
3:18 PM
Myovant Sciences (Filer)
Form DEF 14C
06/04/2019
3:06 PM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
4:17 PM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
4:11 PM
Myovant Sciences (Filer)
Form 424B5
05/29/2019
3:44 PM
Myovant Sciences (Filer)
Form 424B5
05/24/2019
4:13 PM
Myovant Sciences (Filer)
Form S-3ASR
05/24/2019
4:02 PM
Myovant Sciences (Filer)
Form PRE 14C
05/24/2019
3:49 PM
Myovant Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/24/2019
3:21 PM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
8:13 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2019
5:23 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:19 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:16 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:14 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:12 PM
Myovant Sciences (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:25 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
4:14 PM
Myovant Sciences (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
02/14/2019
8:01 AM
Dexxon Holdings Ltd. (Filed by)
Myovant Sciences (Subject)
Form SC 13G/A
02/13/2019
3:06 PM
Machado Patrick (Filed by)
Myovant Sciences (Subject)
Form SC 13G/A
02/13/2019
3:06 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13G/A
02/13/2019
2:36 PM
BB BIOTECH AG (Filed by)
Myovant Sciences (Subject)
Form SC 13G/A
This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel